Ident. | Authors (with country if any) | Title |
---|
000056 |
J. J. Brugts [Pays-Bas] ; Hisatomi Arima [Australie] ; W. Remme [Pays-Bas] ; M. Bertrand [France] ; R. Ferrari [Italie] ; K. Fox [Royaume-Uni] ; J. Dinicolantonio [États-Unis] ; S. Macmahon [Australie] ; J. Chalmers [Australie] ; F. Zijlstra [Pays-Bas] ; K. Caliskan [Pays-Bas] ; M. L. Simoons [Pays-Bas] ; J. J. Mourad [France] ; E. Boersma [Pays-Bas] ; K. M. Akkerhuis [Pays-Bas] | The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease |
001161 |
Jennifer K. Rogers [Royaume-Uni] ; John J. V. Mcmurray [Royaume-Uni] ; Stuart J. Pocock [Royaume-Uni] ; Faiez Zannad [France] ; Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Karl Swedberg [Suède] ; Harry Shi [États-Unis] ; John Vincent [États-Unis] ; Bertram Pitt [États-Unis] | Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations |
001B22 |
Faiez Zannad [France] ; John J. V. Mcmurray [Royaume-Uni] ; Henry Krum [Australie] ; Dirkj. Van Veldhuisen [Pays-Bas] ; Karl Swedberg [Suède] ; Harry Shi [États-Unis] ; John Vincent [États-Unis] ; Stuartj. Pocock [États-Unis] ; Bertram Pitt [États-Unis] | Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms |
001B55 |
Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Christian Funck-Brentano [France] ; Emilio Vanoli [Italie] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Piotr Ponikowski [Pologne] ; Michael Goulder [Royaume-Uni] ; Wilfried Meyer [Allemagne] ; Philippe Lechat [France] ; Ronnie Willenheimer [Suède] | Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial |
002087 |
Shima Mehrabian [France, Bulgarie] ; Emmanuelle Duron [France] ; Florian Labouree [France] ; Florence Rollot [France] ; Alex Bune [Australie] ; Latchezar Traykov [Bulgarie] ; Olivier Hanon [France] | Relationship between orthostatic hypotension and cognitive impairment in the elderly |
002C57 |
Claude Julien [France] ; Sandra L. Burke [Australie] ; Geoffrey A. Head [Australie] | Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits : effect of rilmenidine. Commentary |
003185 |
Luis M. Ruilope [Espagne] ; Bertram Pitt [États-Unis] ; Ali Ahmed [États-Unis] ; Thomas E. Love [États-Unis] ; Henry Krum [Australie] ; Jose Nicolau [Brésil] ; José S. Cardoso [Portugal] ; Alexander Parkhomenko [Ukraine] ; Michael Aschermann [République tchèque] ; Ramon Corbalan [Chili] ; Henry Solomon [États-Unis] ; Harry Shi [États-Unis] ; Faiez Zannad [France] | History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure. Commentary |
003368 |
Emil Toader [France] ; Andrei Cividjian [France] ; Nicolas Rentero [France] ; Robin M. Mcallen [Australie] ; Luc Quintin [France] | Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings |
003A22 |
Enrico Agabiti-Rosei [Italie] ; Giuseppe Mancia [Italie] ; Michael F. O'Rourke [Australie] ; Mary J. Roman [États-Unis] ; Michel E. Safar [France] ; Harold Smulyan [États-Unis] ; Ji-Guang Wang [République populaire de Chine] ; Ian B. Wilkinson [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Charalambos Vlachopoulos [Grèce] | Central blood pressure measurements and antihypertensive therapy : A consensus document |
003D32 |
Olivier Hanon [France] ; Renaud Pequignot [France] ; Marie Laure Seux [France] ; Hermine Lenoir [France] ; Alexandra Bune [Australie] ; Anne Sophie Rigaud [France] ; Francoise Forette [France] ; Xavier Girerd [France] | Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints |
003D54 |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Ken Butcher [Australie] ; Craig Anderson [Australie] ; Marie-Germaine Bousser [France] ; Kennedy R. Lees [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial |
003D55 |
F. Zannad [France] ; M. Kessler [France] ; P. Lehert [Australie, Belgique] ; J. P. Grünfeld [France] ; C. Thuilliez [France] ; A. Leizorovicz [France] ; P. Lechat [France] | Prevention of cardiovascular events in end-stage renal disease : Results of a randomized trial of fosinopril and implications for future studies |
004642 |
Ronnie Willenheimer [Suède] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Allan Skene [Royaume-Uni] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France] | Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence : Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III |
004947 |
Nicola De Luca [Italie] ; Roland G. Asmar [France] ; Gérard M. London [France] ; Michael F. O'Rourke [Australie] ; Michel E. Safare [France] | Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects |
004A68 |
Gérard M. London [France] ; Roland G. Asmar [France] ; Michaël F. O'Rourke [Australie] ; Michel E. Safar [France] | Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol |
004B06 |
Jean L. Rouleau [Canada] ; Ellen B. Roecker [États-Unis] ; Michal Tendera [Pologne] ; Paul Mohacsi [Suisse] ; Henry Krum [Australie] ; Hugo A. Katus [Allemagne] ; Michael B. Fowler [États-Unis] ; Andrew J. S. Coats [Australie] ; Alain Castaigne [France] ; Armin Scherhag [Suisse] ; Terly L. Holcslaw [États-Unis] ; Milton Packer [États-Unis] ; Jay N. Cohn [États-Unis] | Influence of pretreatment systolic blood pressure on the effect of Carvedilol in patients with severe chronic heart failure: The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Author's reply |
004B73 |
N. Chapman [Royaume-Uni] ; R. Huxley [Australie] ; C. Anderson [Nouvelle-Zélande] ; M. G. Bousser [France] ; J. Chalmers [Australie] ; S. Colman [Australie] ; S. Davis [Australie] ; G. Donnan [Australie] ; S. Macmahon [Australie] ; B. Neal [Australie] ; C. Warlow [Royaume-Uni] ; M. Woodward [Australie] | Effects of a perindopril-based blood pressure-lowering regimen on the risk of Recurrent Stroke according to Stroke subtype and medical history: The PROGRESS trial |
004B74 |
Duncan J. Campbell [Australie] ; Theodora Alexiou [Australie] ; Hong D. Xiao [Australie] ; Sebastien Fuchs [Australie] ; Michael J. Mckinley [Australie] ; Pierre Corvol [France] ; Kenneth E. Bernstein [Australie] | Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice |
004D28 |
John Chalmers [Australie] | Etude ADVANCE: objectifs, protocole et état actuel |
005478 |
John B. Kostis [États-Unis] ; Stuart Cobbe [Royaume-Uni] ; Colin Johnston [Australie] ; Ian Ford [Royaume-Uni] ; Michael Murphy [Irlande (pays)] ; Michael A. Weber [États-Unis] ; Henry R. Black [France] ; Pierre Francois Plouin [France] ; Daniel Levy [États-Unis] ; Guiseppe Mancia [Italie] ; Pierre Larochelle [Canada] ; Rainer E. Kolloch [Allemagne] ; Michael Alderman [États-Unis] ; Luis Miguel Ruilope [Espagne] ; Björn Dahlöf [Suède] ; John M. Flack [États-Unis] ; Robert Wolf [États-Unis] | Design of the Omapatrilat in Persons with Enhanced Risk of atherosclerotic events (OPERA) trial |
005508 |
Stéphane Laurent [France] ; Bronwyn Kingwell [Australie] ; Alan Bank [États-Unis] ; Michael Weber [États-Unis] ; Harry Struijker-Boudier [Pays-Bas] | Clinical applications of arterial stiffness: Therapeutics and pharmacology |
005833 |
Roland G. Asmar [France] ; Gérard M. London [France] ; Michael E. O'Rourke [Australie] ; Michel E. Safar [France] | Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol |
005C54 |
Pascal Bousquet [France] ; Monique Dontenwill [France] ; Hugues Greney [France] ; Josiane Feldman [France] | Imidazoline receptors in cardiovascular and metabolic diseases |
006016 |
JIN BO SU [France] ; F. Barbe [France] ; B. Crozatier [France] ; D. J. Campbell [Australie] ; L. Hittinger [France] | Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure |
006065 |
A. Castaigne [France] ; J. Chalmers [Australie] ; T. Morgan [Australie] ; C. Chastang [France] ; L. Feldmann [France] ; D. Guez [France] | Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination : A randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension |
006216 |
T. Morgan [Australie] ; J. Menard [France] ; H. Brunner [Suisse] | Twenty-four hour blood pressure control and trough to peak ratio : who, when, how and why? : Trough to peak ratios |
006218 |
T. Morgan [Australie] ; J. Menard [France] ; H. Brunner [Suisse] | Trough to peak ratio as a guide to BP control: measurement and calculation : Trough to peak ratios |
006384 |
R. M. Schaefer [Allemagne] ; P. M. Aldons ; E. D. Burgess ; R. Tilvis [Finlande] ; X. Girerd [France] ; G. P. Singh [Nouvelle-Zélande] ; L. Rehn ; T. O. Morgan [Australie] | Improved tolerability of felodipine compared with amlodipine in elderly hypertensives : A randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events |
006442 |
J. Feldman [France] ; H. Greney [France] ; L. Monassier [France] ; C. Vonthron [France] ; V. Bruban [France] ; M. Dontenwill [France] ; P. Bousquet [France] | Does a second generation of centrally acting antihypertensive drugs really exist? |
006609 |
J. Menard [France] ; D. J. Campbell [Australie] ; M. Azizi [France] ; M.-F. Gonzales [France] | Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats |
006834 |
| |
006B04 |
R. W. Sanson-Fisher [Australie] ; K. Clover | Compliance in the treatment of hypertension : a need for action |
006B94 |
L. Hansson [Suède] | The place of β-blockers in the treatment of hypertension in 1993 |
006B95 |
C. I. Johnston [Australie] | The place of diuretics in the treatment of hypertension in 1993 : can we do better ? |
006B96 |
J. Chalmers [Australie] | The place of combination therapy in the treatment of hypertension in 1993 |
006B97 |
J. L. Reid [Royaume-Uni] | The place of alpha blockers in the treatment of hypertension |
006C38 |
P. A. Van Zwieten [Pays-Bas] | New avenues in antihypertensive drug treatment |
006C47 |
A. F. Lever [Royaume-Uni] ; P. J. Brennan | MRC trial of treatment in elderly hypertensives |
006C65 |
P. K. Whelton [États-Unis] ; F. Brancati | Hypertension management in populations |
006C70 |
L. A. Salako [Nigeria] | Hypertension in Africa and effectiveness of its management with various classes of antihypertensive drugs and in different socio-economic and cultural environments |
006C90 |
C. J. Bulpitt [Royaume-Uni] ; A. E. Fletcher | Cost-effectiveness of the treatment of hypertension |
006C94 |
A. F. Schaub [Suisse] ; A. Steiner ; W. Vetter | Compliance to treatment |
006C96 |
J. A. Cutler [États-Unis] | Combinations of lifestyle modification and drug treatment in management of mild-moderate hypertension : a review of randomized clinical trials |
006D01 |
F. C. Luft [Allemagne] ; H. Haller | Calcium channel blockers in current medical practice : an update for 1993 |
006D08 |
L. Thijs [Belgique] ; A. Amery ; R. Antikainen ; P. Bert ; W. Birkenh Ger ; C. J. Bulpitt ; C. T. Dollery ; A. E. Fletcher ; F. Forette ; T. Hakam Ki ; P. Kivinen ; E. Lehtomaki ; E. O'Brien ; C. Sarti ; J. Staessen ; R. Tilvis ; B. Trimarco ; J. Tuomilehto ; H. Vanhanen ; O. V Nska ; J. Webster ; Y. Yodfat | Antihypertensive therapy in elderly patients with isolated systolic hypertension : third progress report of the syst-eur trial |
006D10 |
J. L. Rodicio [Espagne] ; L. M. Ruilope | Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension |
006D11 |
H. R. Brunner [Suisse] ; J. Nussberger ; M. Burnier ; B. Waeber | Angiotensin II antagonists |
006D20 |
| |